Drug profile · INN
gadopiclenol
ELUCIREM
gadopiclenol (ELUCIREM) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.
FDA: approved EMA: approved Various (V08) V08CA12
US status approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — gadopiclenol
- US status
- approved
- Class
- Various (V08)
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
gadopiclenol (ELUCIREM) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN gadopiclenol
Brand ELUCIREM
Mechanism Diagnostic agent
Therapeutic class Various (V08)
Route INTRAVENOUS
Formulation SOLUTION
ATC code V08CA12
Mechanism of action
Diagnostic agent
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is gadopiclenol?
gadopiclenol (ELUCIREM) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for gadopiclenol?
ELUCIREM is a marketed brand name for gadopiclenol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of gadopiclenol?
gadopiclenol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.